Basic & Clinical Medicine ›› 2021, Vol. 41 ›› Issue (5): 753-757.

• Mini Reviews • Previous Articles     Next Articles

Research progress of acidic nucleoplasmic DNA-binding protein 1

CUI Ya-ting1, GOU Wen-feng2, WEI Hui-qiang2, YU Jiang2, HOU Wen-bin2*, LI Yi-liang2*   

  1. 1. Tianjin University of Traditional Chinese Medicine,Tianjin 301617;
    2. Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, CAMS & PUMC, Tianjin 300192, China
  • Received:2021-03-08 Revised:2021-03-20 Online:2021-05-05 Published:2021-05-06
  • Contact: *liyiliang@irm-cams.ac.cn; houwenbin@irm-cams.ac.cn

Abstract: Acidic nucleoplasmic DNA-binding protein 1 (And-1/WDHD1) as a natural chimerical protein, is characterized by containing the WD-repeat and the HMG-box motif families. And-1 is over-expressed in multiple tumors and involved in the whole cell cycle containing prereplication complex (Pre-RC) assembly, DNA replication, checkpoint activation, DNA repair and sister chromatid cohesion establishment. As a novel target for cell cycle regulation, And-1 can be used in the development of broad-spectrum anti-cancer drugs. This article focuses on the research on the structural characteristics, biochemical functions and potential roles of And-1 in cancer in recent years, in order to provide references for the further research of And-1 and the development of new drugs.

Key words: acidic nucleoplasmic DNA-binding protein 1(And-1), WD40(WD-repeat), high mobility group(HMG), novel target

CLC Number: